rs6009961

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001097.3(ACR):​c.566-4A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.708 in 1,482,114 control chromosomes in the GnomAD database, including 387,615 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.74 ( 41958 hom., cov: 26)
Exomes 𝑓: 0.70 ( 345657 hom. )

Consequence

ACR
NM_001097.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.0001893
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.377
Variant links:
Genes affected
ACR (HGNC:126): (acrosin) Acrosin is the major proteinase present in the acrosome of mature spermatozoa. It is a typical serine proteinase with trypsin-like specificity. It is stored in the acrosome in its precursor form, proacrosin. The active enzyme functions in the lysis of the zona pellucida, thus facilitating penetration of the sperm through the innermost glycoprotein layers of the ovum. The mRNA for proacrosin is synthesized only in the postmeiotic stages of spermatogenesis. In humans proacrosin first appears in the haploid spermatids. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 22-50744057-A-G is Benign according to our data. Variant chr22-50744057-A-G is described in ClinVar as [Benign]. Clinvar id is 402335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.87 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACRNM_001097.3 linkuse as main transcriptc.566-4A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000216139.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACRENST00000216139.10 linkuse as main transcriptc.566-4A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_001097.3 P1

Frequencies

GnomAD3 genomes
AF:
0.737
AC:
111259
AN:
150872
Hom.:
41911
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.877
Gnomad AMI
AF:
0.747
Gnomad AMR
AF:
0.662
Gnomad ASJ
AF:
0.717
Gnomad EAS
AF:
0.419
Gnomad SAS
AF:
0.531
Gnomad FIN
AF:
0.702
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.716
Gnomad OTH
AF:
0.736
GnomAD3 exomes
AF:
0.657
AC:
161125
AN:
245076
Hom.:
54934
AF XY:
0.653
AC XY:
86473
AN XY:
132516
show subpopulations
Gnomad AFR exome
AF:
0.888
Gnomad AMR exome
AF:
0.561
Gnomad ASJ exome
AF:
0.702
Gnomad EAS exome
AF:
0.411
Gnomad SAS exome
AF:
0.538
Gnomad FIN exome
AF:
0.699
Gnomad NFE exome
AF:
0.713
Gnomad OTH exome
AF:
0.667
GnomAD4 exome
AF:
0.705
AC:
938035
AN:
1331128
Hom.:
345657
Cov.:
31
AF XY:
0.699
AC XY:
465895
AN XY:
666922
show subpopulations
Gnomad4 AFR exome
AF:
0.893
Gnomad4 AMR exome
AF:
0.579
Gnomad4 ASJ exome
AF:
0.702
Gnomad4 EAS exome
AF:
0.396
Gnomad4 SAS exome
AF:
0.541
Gnomad4 FIN exome
AF:
0.711
Gnomad4 NFE exome
AF:
0.731
Gnomad4 OTH exome
AF:
0.705
GnomAD4 genome
AF:
0.738
AC:
111370
AN:
150986
Hom.:
41958
Cov.:
26
AF XY:
0.728
AC XY:
53684
AN XY:
73694
show subpopulations
Gnomad4 AFR
AF:
0.877
Gnomad4 AMR
AF:
0.662
Gnomad4 ASJ
AF:
0.717
Gnomad4 EAS
AF:
0.420
Gnomad4 SAS
AF:
0.531
Gnomad4 FIN
AF:
0.702
Gnomad4 NFE
AF:
0.715
Gnomad4 OTH
AF:
0.739
Alfa
AF:
0.724
Hom.:
8417
Bravo
AF:
0.739

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 66% of total chromosomes in ExAC -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
5.1
DANN
Benign
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00019
dbscSNV1_RF
Benign
0.022
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6009961; hg19: chr22-51182485; COSMIC: COSV53360590; COSMIC: COSV53360590; API